Mirabaud & Cie SA boosted its stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 8.7% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 54,311 shares of the company's stock after purchasing an additional 4,348 shares during the quarter. Procter & Gamble comprises about 2.8% of Mirabaud & Cie SA's holdings, making the stock its 13th biggest position. Mirabaud & Cie SA's holdings in Procter & Gamble were worth $8,653,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors have also bought and sold shares of the company. Nova Wealth Management Inc. acquired a new position in shares of Procter & Gamble during the first quarter valued at about $26,000. Capital A Wealth Management LLC bought a new position in shares of Procter & Gamble during the fourth quarter valued at about $31,000. Quarry LP bought a new position in shares of Procter & Gamble during the first quarter valued at about $33,000. 10Elms LLP bought a new position in shares of Procter & Gamble during the fourth quarter valued at about $34,000. Finally, Mizuho Securities Co. Ltd. lifted its position in shares of Procter & Gamble by 566.7% during the first quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company's stock valued at $34,000 after purchasing an additional 170 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
PG has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. reissued a "neutral" rating and set a $170.00 price target (down from $178.00) on shares of Procter & Gamble in a research report on Friday, July 25th. Evercore ISI reissued an "in-line" rating and set a $170.00 price target (down from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. UBS Group set a $180.00 price objective on shares of Procter & Gamble and gave the stock a "buy" rating in a research report on Wednesday, July 30th. Wells Fargo & Company lowered their price objective on shares of Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 30th. Finally, Barclays set a $164.00 price objective on shares of Procter & Gamble and gave the stock an "equal weight" rating in a research report on Thursday, July 31st. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat, Procter & Gamble currently has an average rating of "Moderate Buy" and a consensus target price of $175.12.
Read Our Latest Research Report on PG
Insider Activity at Procter & Gamble
In related news, CEO Gary A. Coombe sold 10,194 shares of the business's stock in a transaction that occurred on Thursday, August 21st. The shares were sold at an average price of $158.16, for a total transaction of $1,612,283.04. Following the completion of the transaction, the chief executive officer owned 34,978 shares of the company's stock, valued at approximately $5,532,120.48. The trade was a 22.57% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Andre Schulten sold 11,638 shares of the business's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $1,830,308.26. Following the transaction, the chief financial officer directly owned 52,642 shares of the company's stock, valued at approximately $8,279,007.34. This represents a 18.11% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 120,181 shares of company stock valued at $18,918,012 in the last quarter. 0.20% of the stock is currently owned by company insiders.
Procter & Gamble Stock Performance
NYSE PG opened at $158.02 on Monday. The company's 50 day moving average is $156.21 and its 200-day moving average is $161.77. Procter & Gamble Company has a 12-month low of $149.91 and a 12-month high of $180.43. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. The firm has a market cap of $369.85 billion, a P/E ratio of 24.27, a price-to-earnings-growth ratio of 4.17 and a beta of 0.36.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. During the same quarter in the previous year, the firm posted $1.40 earnings per share. The company's quarterly revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Sell-side analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were paid a dividend of $1.0568 per share. The ex-dividend date of this dividend was Friday, July 18th. This represents a $4.23 annualized dividend and a yield of 2.7%. Procter & Gamble's payout ratio is currently 64.82%.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.